This novel finding not only indicated that an additional mechanism exists in pancreatic cancer cells to mediate the effects of 5-Lox, but also it suggested that the 5-Lox activity feeds a survival mechanism which may help pancreatic cancer cells to bypass chemotherapies that are directed against Akt. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.